Evaluate treatment promptly for benefit/risk ratio of continuing if abnormal neurologic signs and symptoms develop. Severe hepatic impairment (Child-Pugh C): reduce metronidazole dose by 50%.

Evaluate treatment promptly for benefit/risk ratio of continuing if abnormal neurologic signs and symptoms develop. Severe hepatic impairment (Child-Pugh C): reduce metronidazole dose by 50%.

A prospective, randomized, controlled clinical trial compared metronidazole 250 mg orally four ... for patients to begin a lower-dosage regimen for CDAD treatment, increasing the dosage if the ...

(2010) Japan PPI (standard dose b.i.d.) Clarithromycin (200–400 mg b.i.d.) Amoxicillin (750 mg b.i.d.) 7 Metronidazole-containing triple therapy is not recommended as first-line treatment ...

the patients were treated with secnidazole (30 mg/kg single dose) and metronidazole (15 mg/kg tid for 7 days) randomly. Two weeks after the end of treatment, direct and formol- ether fecal ...